{"nct_id":"NCT01295827","title":"Study of Pembrolizumab (MK-3475) in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001)","status":"COMPLETED","status_verified_date":"2019-11","start_date":"2011-03-04","start_date_type":"ACTUAL","primary_completion_date":"2018-11-05","primary_completion_date_type":"ACTUAL","completion_date":"2018-12-11","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}